Global Cardiac Biomarkers Market - Growth, Trends and Forecasts (2017 - 2022)

  • ID: 4402773
  • Report
  • Region: Global
  • 120 pages
  • Mordor Intelligence
1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Alere Inc.
  • Beckman Coulter Inc.
  • Biomeriux
  • Bio-Rad Laboratories
  • Randox Laboratories
  • MORE
The market is estimated to be USD XX billion in 2017 and is expected to reach USD XX billion by 2022, registering a healthy CAGR of XX%, during 2017-2022 (forecast period).

Cardiac biomarkers are substances released into the blood, when the heart is under stress or not functioning properly. The measurements of these biomarkers are used to diagnose some illnesses, such as acute coronary syndrome (ACS) and cardiac ischemia, and conditions associated with insufficient blood flow to the heart. The tests for cardiac biomarkers can also be used to determine the risks of getting diagnosed and help manage the patients with these conditions.

The increasing prevalence of cardiovascular diseases, along with the increasing need for cost-efficient and non-invasive techniques for the treatment are the major factors driving the market. However, factors, such as issues related to regulatory and reimbursement systems are decelerating the market. The emergence of personalized medicines in recent years are creating opportunities for the market, as biomarkers play an important role in customizing medicines.

The global cardiac biomarkers market is segmented based on the type, application, location of testing and geography. The North American market for cardiac biomarkers is expected to hold the largest share, globally, owing to the rapid technological advancements in various cardiac biomarker combinations.

Some of the major players in this market are:

Abbott Laboratories
Alere Inc
Siemens Healthcare
Roche Diagnostics Corporation
Beckman Coulter Inc
Becton Dickinson and Company
Thermo Fisher Scientific
Biomeriux
Bio-Rad Laboratories
Randox Laboratories

Key Deliverables

Market analysis, with region-specific assessments and competition analysis on a global and regional scale.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, growing prospective opportunities, and identification of key companies that can influence the market.

Extensively researched competitive landscape section with profiles of major companies, along with their market share.

Identification and analysis of the macro and micro factors that affect the market on both, global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-range of knowledge and insights about the major players in the industry and the key strategies adopted by them to sustain and grow in the studied market
Insights on the major countries/regions where the industry is growing, and identify the regions that are still untapped.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Alere Inc.
  • Beckman Coulter Inc.
  • Biomeriux
  • Bio-Rad Laboratories
  • Randox Laboratories
  • MORE
1. Introduction
1.1 Market Definition
1.2 Research Methodology

2. Executive Summary

3. Key Inferences

4. Market Overview
4.1 Current Market Scenario
4.2 Porter's Five Forces Analysis
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Consumers
4.2.3 Threat of New Entrants
4.2.4 Threat of Substitute Products and Services
4.2.5 Competitive Rivalry within the Industry

5. Drivers, Restraints, Opportunities & Challenges Analysis (DROC)
5.1 Market Drivers
5.1.1 Increasing Prevalence of Cardiovascular Diseases
5.1.2 Need for Cost effective & Non-invasive techniques for Treating Cardiovascular Diseases
5.1.3 Technological Advancements Using Cardiac Biomarkers Combinations
5.1.4 Growing Funding from Public-

Private Organizations for Research on Cardiac Biomarkers
5.2 Market Restraints
5.2.1 Issues Related to Regulatory and Reimbursement Systems
5.3 Market Opportunities
5.3.1 Increasing Point of Care (POC) testing
5.4 Market Challenges

6. Market Segmentation
6.1 By Type of Marker
6.1.1 Creatine Kinase
6.1.2 Troponins (T,I)
6.1.3 Myoglobin
6.1.4 Natriuretic peptides (BNP and NT-proBNP)
6.1.5 Ischemia Modified Albumin
6.1.6 Others
6.2 By Application
6.2.1 Myocardial Infarction
6.2.2 Congestive Heart Failure
6.2.3 Acute Coronary Syndrome
6.2.4 Atherosclerosis
6.2.5 Others
6.3 By Location of Testing
6.3.1 Point of care testing
6.3.2 Laboratory testing
6.4 By Geography
6.4.1 North America
6.4.1.1 United States
6.4.1.2 Canada
6.4.1.3 Mexico
6.4.2 Europe
6.4.2.1 United Kigdom
6.4.2.2 Spain
6.4.2.3 Italy
6.4.2.4 France
6.4.2.5 Germany
6.4.2.6 Rest of Europe
6.4.3 Asia-Pacific
6.4.3.1 Japan
6.4.3.2 China
6.4.3.3 India
6.4.3.4 South Korea
6.4.3.5 Australia & New Zealand
6.4.3.6 Rest of Asia-Pacific
6.4.4 Middle East & Africa
6.4.4.1 GCC
6.4.4.2 South Africa
6.4.4.3 Rest of Middle East & Africa
6.4.5 South America
6.4.5.1 Brazil
6.4.5.2 Argentina
6.4.5.3 Rest of South America

7. Competitive Landscape
7.1 Mergers and Acquisitions
7.2 Partnerships, Collaborations and Agreements
7.3 New Product Launches

8. Company Profiles
8.1 Abbott laboratories
8.2 Alere Inc.
8.3 Siemens Healthcare
8.4 Roche Diagnostics Corporation
8.5 Beckman Coulter
8.6 Becton, Dickinson And Co.
8.7 Thermo Fisher Scientific
8.8 BioMerieux
8.9 Bio-Rad Laboratories
8.10 Randox laboratories

9. Future Market Scenario
1. Introduction
1.1 Market Definition
1.2 Research Methodology

2. Executive Summary

3. Key Inferences

4. Market Overview
4.1 Current Market Scenario
4.2 Porter's Five Forces Analysis
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Consumers
4.2.3 Threat of New Entrants
4.2.4 Threat of Substitute Products and Services
4.2.5 Competitive Rivalry within the Industry

5. Drivers, Restraints, Opportunities & Challenges Analysis (DROC)
5.1 Market Drivers
5.1.1 Increasing Prevalence of Cardiovascular Diseases
5.1.2 Need for Cost effective & Non-invasive techniques for Treating Cardiovascular Diseases
5.1.3 Technological Advancements Using Cardiac Biomarkers Combinations
5.1.4 Growing Funding from Public-

Private Organizations for Research on Cardiac Biomarkers
5.2 Market Restraints
5.2.1 Issues Related to Regulatory and Reimbursement Systems
5.3 Market Opportunities
5.3.1 Increasing Point of Care (POC) testing
5.4 Market Challenges

6. Market Segmentation
6.1 By Type of Marker
6.1.1 Creatine Kinase
6.1.2 Troponins (T,I)
6.1.3 Myoglobin
6.1.4 Natriuretic peptides (BNP and NT-proBNP)
6.1.5 Ischemia Modified Albumin
6.1.6 Others
6.2 By Application
6.2.1 Myocardial Infarction
6.2.2 Congestive Heart Failure
6.2.3 Acute Coronary Syndrome
6.2.4 Atherosclerosis
6.2.5 Others
6.3 By Location of Testing
6.3.1 Point of care testing
6.3.2 Laboratory testing
6.4 By Geography
6.4.1 North America
6.4.1.1 United States
6.4.1.2 Canada
6.4.1.3 Mexico
6.4.2 Europe
6.4.2.1 United Kigdom
6.4.2.2 Spain
6.4.2.3 Italy
6.4.2.4 France
6.4.2.5 Germany
6.4.2.6 Rest of Europe
6.4.3 Asia-Pacific
6.4.3.1 Japan
6.4.3.2 China
6.4.3.3 India
6.4.3.4 South Korea
6.4.3.5 Australia & New Zealand
6.4.3.6 Rest of Asia-Pacific
6.4.4 Middle East & Africa
6.4.4.1 GCC
6.4.4.2 South Africa
6.4.4.3 Rest of Middle East & Africa
6.4.5 South America
6.4.5.1 Brazil
6.4.5.2 Argentina
6.4.5.3 Rest of South America

7. Competitive Landscape
7.1 Mergers and Acquisitions
7.2 Partnerships, Collaborations and Agreements
7.3 New Product Launches

8. Company Profiles
8.1 Abbott laboratories
8.2 Alere Inc.
8.3 Siemens Healthcare
8.4 Roche Diagnostics Corporation
8.5 Beckman Coulter
8.6 Becton, Dickinson And Co.
8.7 Thermo Fisher Scientific
8.8 BioMerieux
8.9 Bio-Rad Laboratories
8.10 Randox laboratories

9. Future Market Scenario
1. Introduction
1.1 Market Definition
1.2 Research Methodology

2. Executive Summary

3. Key Inferences

4. Market Overview
4.1 Current Market Scenario
4.2 Porter's Five Forces Analysis
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Consumers
4.2.3 Threat of New Entrants
4.2.4 Threat of Substitute Products and Services
4.2.5 Competitive Rivalry within the Industry

5. Drivers, Restraints, Opportunities & Challenges Analysis (DROC)
5.1 Market Drivers
5.1.1 Increasing Prevalence of Cardiovascular Diseases
5.1.2 Need for Cost effective & Non-invasive techniques for Treating Cardiovascular Diseases
5.1.3 Technological Advancements Using Cardiac Biomarkers Combinations
5.1.4 Growing Funding from Public-

Private Organizations for Research on Cardiac Biomarkers
5.2 Market Restraints
5.2.1 Issues Related to Regulatory and Reimbursement Systems
5.3 Market Opportunities
5.3.1 Increasing Point of Care (POC) testing
5.4 Market Challenges

6. Market Segmentation
6.1 By Type of Marker
6.1.1 Creatine Kinase
6.1.2 Troponins (T,I)
6.1.3 Myoglobin
6.1.4 Natriuretic peptides (BNP and NT-proBNP)
6.1.5 Ischemia Modified Albumin
6.1.6 Others
6.2 By Application
6.2.1 Myocardial Infarction
6.2.2 Congestive Heart Failure
6.2.3 Acute Coronary Syndrome
6.2.4 Atherosclerosis
6.2.5 Others
6.3 By Location of Testing
6.3.1 Point of care testing
6.3.2 Laboratory testing
6.4 By Geography
6.4.1 North America
6.4.1.1 United States
6.4.1.2 Canada
6.4.1.3 Mexico
6.4.2 Europe
6.4.2.1 United Kigdom
6.4.2.2 Spain
6.4.2.3 Italy
6.4.2.4 France
6.4.2.5 Germany
6.4.2.6 Rest of Europe
6.4.3 Asia-Pacific
6.4.3.1 Japan
6.4.3.2 China
6.4.3.3 India
6.4.3.4 South Korea
6.4.3.5 Australia & New Zealand
6.4.3.6 Rest of Asia-Pacific
6.4.4 Middle East & Africa
6.4.4.1 GCC
6.4.4.2 South Africa
6.4.4.3 Rest of Middle East & Africa
6.4.5 South America
6.4.5.1 Brazil
6.4.5.2 Argentina
6.4.5.3 Rest of South America

7. Competitive Landscape
7.1 Mergers and Acquisitions
7.2 Partnerships, Collaborations and Agreements
7.3 New Product Launches

8. Company Profiles
8.1 Abbott laboratories
8.2 Alere Inc.
8.3 Siemens Healthcare
8.4 Roche Diagnostics Corporation
8.5 Beckman Coulter
8.6 Becton, Dickinson And Co.
8.7 Thermo Fisher Scientific
8.8 BioMerieux
8.9 Bio-Rad Laboratories
8.10 Randox laboratories

9. Future Market Scenario
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Abbott Laboratories
  • Alere Inc.
  • Siemens Healthcare
  • Roche Diagnostics Corporation
  • Beckman Coulter Inc.
  • Becton Dickinson and Company
  • Thermo Fisher Scientific
  • Biomeriux
  • Bio-Rad Laboratories
  • Randox Laboratories
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll